NCT04869046

Brief Summary

The study analysed direct levobupivacaine instillation in surgical wound and its effectiveness in postoperative pain control. Half participants received 0,5 % levobupivacaine and the other half received 0,9% saline solution

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for phase_4 postoperative-pain

Timeline
Completed

Started Mar 2013

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2013

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
6.2 years until next milestone

First Submitted

Initial submission to the registry

February 3, 2020

Completed
1.2 years until next milestone

First Posted

Study publicly available on registry

May 3, 2021

Completed
Last Updated

May 6, 2021

Status Verified

May 1, 2021

Enrollment Period

9 months

First QC Date

February 3, 2020

Last Update Submit

May 1, 2021

Conditions

Keywords

postoperative painherniachildrenlevobupivacaineinstillation

Outcome Measures

Primary Outcomes (2)

  • Postoperative pain assessment

    Assessment of pain by Face, Legs, Activity, Cry Consolability scale (nurse is observer) regularly, around the clock, first time 30 minutes after surgery, than after every 6 hours, until 24 h after surgery. Each score higher than 3 is considered significant and and an analgesic was given

    "Min 30" if no changes "Hour 6"

  • Analgesic efficacy of nonopioid analgesic mixture

    30 minutes after taking analgesic mixture, the Face, Legs, Activity, Cry Consolability pain scale assessment was performed. Each score higher than 3 is considered significant and planed nonopioid analgesic was given. Frequency of nonsteroidal anti-inflammatory drug administration needed in 24 hour timeframe and time interval between doses were used as a measure of the analgesic effectiveness

    as needed in 24 hours

Secondary Outcomes (1)

  • Control of breakthrough pain

    as needed in 24 hours

Study Arms (2)

Levobupivacaine group

EXPERIMENTAL

Instillation of 0,1 ml/kg (0,5 mg/kg) levobupivacaine 0,5% in surgical wound before fascia closure

Drug: Instillation of levobupivacaine in surgical wound

Control Group

PLACEBO COMPARATOR

Instillation of 0,1 ml/kg 0,9% Sodium Chloride in surgical wound before fascia closure

Drug: Instillation of levobupivacaine in surgical wound

Interventions

Once the hernia tissue had been surgically managed, the wound was sutured in layers and a solution of 0.5% levobupivacaine, 0.5 mg/kg (0.1 ml/kg), was instilled into the wound of children in the experimental group before suturing of the abdominal fascia. That same amount of 0.9% saline was given to children in the control group. The absorption of the solution took approximately 3 minutes, after which the wound was sutured. After completion of wound suturing, all children received 20 mg/kg of paracetamol administered as a rectal suppository.

Also known as: Enteral analgesic mixture acetaminophen 10 mg/kg and ibuprofen 5mg/kg if needed, Acetaminophen, Ibuprofen
Control GroupLevobupivacaine group

Eligibility Criteria

Age6 Months - 7 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • elective surgery
  • not having incarcerated hernia
  • not having previous surgeries requiring general anaesthesia American Society of Anesthesia scores I and II
  • not having allergy to topical anesthetics, paracetamol, ibuprofen and/or general anesthetics, opioids or muscle relaxants

You may not qualify if:

  • worsening of health status prior to surgery
  • parental withdrawal to study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Institut for Mother and Child HealthCare "Dr Vukan Cupic"

Belgrade, +38111, Serbia

Location

Institute for Mother and Child Health Care Dr Vukan Cupic

Belgrade, Serbia

Location

Related Publications (3)

  • Williams G, Howard RF, Liossi C. Persistent postsurgical pain in children and young people: prediction, prevention, and management. Pain Rep. 2017 Aug 21;2(5):e616. doi: 10.1097/PR9.0000000000000616. eCollection 2017 Sep.

    PMID: 29392231BACKGROUND
  • Matsota P, Papageorgiou-Brousta M, Kostopanagiotou G. Wound infiltration with levobupivacaine: an alternative method of postoperative pain relief after inguinal hernia repair in children. Eur J Pediatr Surg. 2007 Aug;17(4):270-4. doi: 10.1055/s-2007-965473.

    PMID: 17806025BACKGROUND
  • Dogra N, Dadheech R, Dhaka M, Gupta A. A study to compare caudal levobupivacaine, tramadol and a combination of both in paediatric inguinal hernia surgeries. Indian J Anaesth. 2018 May;62(5):359-365. doi: 10.4103/ija.IJA_747_17.

    PMID: 29910493BACKGROUND

MeSH Terms

Conditions

Pain, PostoperativeHernia

Interventions

IbuprofenAcetaminophen

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Anatomical

Intervention Hierarchy (Ancestors)

PhenylpropionatesAcids, CarbocyclicCarboxylic AcidsOrganic ChemicalsAcetanilidesAnilidesAmidesAniline CompoundsAmines

Study Officials

  • Sonja Vuckovic, MD, PhD

    University of Belgrade Faculty of Medicine

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Maja Sujica, Head of Department of Anesthesiology and Intensive Care

Study Record Dates

First Submitted

February 3, 2020

First Posted

May 3, 2021

Study Start

March 1, 2013

Primary Completion

December 1, 2013

Study Completion

December 1, 2013

Last Updated

May 6, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will not share

Locations